Promising inhibition of diabetes-related enzymes and antioxidant properties of Ptilostemon casabonae leaves extract

Cinzia Sanna,Antonella Fais,Benedetta Era,Giovanna L. Delogu,Enrico Sanna,Laura Dazzi,Antonella Rosa,Arianna Marengo,Patrizia Rubiolo,Antonio De Agostini,Sonia Floris,Francesca Pintus,Cinzia SannaAntonella FaisBenedetta EraGiovanna L. DeloguEnrico SannaLaura DazziAntonella RosaArianna MarengoPatrizia RubioloAntonio De AgostiniSonia FlorisFrancesca Pintusa Department of Life and Environmental Sciences,University of Cagliari,Cagliari,Italyb Department of Biomedical Science,University of Cagliari,Cagliari,Italyc Department of Drug Science and Technology,University of Turin,Turin,Italy
DOI: https://doi.org/10.1080/14756366.2023.2274798
2023-11-01
Journal of Enzyme Inhibition and Medicinal Chemistry
Abstract:Type 2 diabetes (T2D) is a progressive metabolic disorder of glucose metabolism. One of the therapeutic approaches for the treatment of T2D is reducing postprandial hyperglycaemia through inhibition of the digestive enzymes α-glucosidase and α-amylase. In this context, aimed at identifying natural products endowed with anti-T2D potential, we focused on Ptilostemon casabonae (L.) Greuter, a species belonging to Asteraceae family. Enzymatic inhibition, antioxidant activity, phenolic composition and cellular assays were performed. This study revealed that the P. casabonae hydroalcoholic extract exerts a potent inhibitory activity against α-glucosidase. This activity is supported by an antioxidant effect, preventing ROS formation in a stressed cellular system. HPLC-PDA-MS/MS analysis, revealed a complex polyphenolic fraction. Among the tested pure compounds, 1,5-dicaffeoylquinic acid, apigenin and rutin displayed good α-glucosidase inhibitory activity. Our study suggested new potential of P. casabonae encouraging us to further testing the possible therapeutic potential of this extract.
biochemistry & molecular biology,chemistry, medicinal
What problem does this paper attempt to address?